CUV 0.00% $14.30 clinuvel pharmaceuticals limited

News: CUV UPDATE 1-U.S. FDA approves Clinuvel Pharma's rare genetic disorder treatment, page-108

  1. 422 Posts.
    lightbulb Created with Sketch. 84
    What do you think the shorter's exit strategy might be? You make a compelling case for a short squeeze when they do, but number of shorts is still ticking up which suggests short conviction. But no-one seems to know what the short thesis might be, merely pointing to what looks like extreme over-valuation until you consider the earnings growth likely over the next two years and starting soon - as you have explained very well. So what is the short thesis??
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.